Novel "reverse Kahne-type glycosylation": Access to O-, N-, and C-linked epipodophyllotoxin conjugates

Organic Letters

Volumn 2, Issue 8, 2000, Pages 1149-1152

  Berkowitz, David B ^a   Choi, Sungjo ^a   Bhuniya, Debnath ^a   Shoemaker, Richard K ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; NITROGEN; OXYGEN; PODOPHYLLOTOXIN;

ARTICLE; CHEMISTRY; GLYCOSYLATION;

CARBON; GLYCOSYLATION; NITROGEN; OXYGEN; PODOPHYLLOTOXIN;

EID: 0034689853     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol005732a     Document Type: Article

References (45)

1. (a) Imbert, T. F. Biochimie 1998, 80, 207-222.
2. (b) Damayanthi, Y.; Lown, J. W. Curr. Med. Chem. 1998, 5, 205-252.
3. (c) Hande, K. R. Eur. J. Cancer 1998, 34, 1514-1521.
4. (d) Pommier, Y.; Fesen, M. R.; Goldwasser, F. In Cancer Chemotherapy and Biotherapy: Principles and Practice; Chabner, B. A., Longo, S. L., Eds.; Lippincoltt Raven: Philadephia, 1996; pp 435-461.
5. (a) Wang, Y.; Rea, T.; Bian, J.; Gray, S.; Sum, Y. FEBS Lett. 1999, 445, 269-273.
6. (b) Burden, D. A.; Osheroff, N. Biochim. Biophys. Acta 1998, 1400, 139-154.
7. (c) Gantchev, T. G.; Hunting, D. J. Mol. Pharmacol. 1998, 53, 422-428.
8. (d) Froelich-Ammon, S. J.; Osheroff, N. J. Biol. Chem. 1995, 270, 21429-21432.
9. de Jong, R. S.; Slijfer, E. A. M.; Uges, D. R. A.; Mulder, N. H.; de Vries, E. G. E. Br. J. Cancer 1997, 76, 1480-1483.
10. Rassmann, I.; Thodtmann, R.; Mross, M.; Huttmann, A.; Berdel, W. E.; Manegold, C.; Fiebig, H. H.; Kaeserfrolich, A.; Burk, K.; Hanauske, A. R. Invest. New Drugs 1998, 16, 319-324.
11. Utsugi, T.; Shibata, J.; Sugimoto, Y.; Aoyagi, K.; Wierzba, K.; Kobunai, T.; Terada, T.; Oh-hara, T.; Tsuruo, T.; Yamada, Y. Cancer Res. 1996, 56, 2809-2814.
12. Zhang, Y.-L.; Tropsha, A.; McPhail, A. T.; Lee, K.-H. J. Med. Chem. 1994, 37, 1460-1464.
13. Huang, T.-S.; Lee, C.-C.; Chao, Y.; Shu, C.-H.; Chen, L.-T.; Chen, L.-L.; Chen, M.-H.; Yuan, C.-C.; Whang-Peng, J. Pharm. Res. 1999, 16, 997-1002.
14. Berkowitz, D. B.; Choi, S.; Maeng, J.-H. J. Org. Chem. 2000, 65, 847-860.
15. (a) Loike, J. D.; Horwitz, S. B. Biochemistry 1976, 15, 5443-5448.
16. (b) Long, B. H.; Musial, S. T.; Brattain, M. G. Biochemistry 1984, 23, 1183-1188.
17. Kuhn, M.; von Wartburg, A. Helv. Chim. Acta 1968, 51, 163-168.
18. For an alternative glycosylation of (epi)podophyllotoxin, in which a glucosyl phosphinimidate or phosphate serves as glycosyl donor, see: Hashimoto, S.; Honda, T.; Ikegami, S. Tetrahedron Lett. 1991, 32, 1653-1654.
19. (a) Kuhn, M.; von Wartburg, A. Helv. Chim. Acta 1968, 51, 1631-1640.
20. (b) Kolar, C.; Moldenhauer, H.; Kneissl, G. J. Carbohydr. Chem. 1990, 571-583.
21. (c) Allevi, P.; Anastasia, M.; Ciuffreda, P.; Sanvito, A. M.; Macdonald, P. Tetrahedron Lett. 1992, 33, 4831-4834.
22. (a) Allevi, P.; Anastasia, M.; Ciuffreda, P.; Bigatti, E.; Macdonald, P. J. Org. Chem. 1993, 58, 4175-4178.
23. (b) Vogel, K.; Sterling, J.; Herzig, Y.; Nudelman, A. Tetrahedron 1996, 52, 3049-3056.
24. (c) Daley, L.; Guminski, Y.; Demerseman, P.; Kruczynski, A.; Etievant, C.; Imbert, T.; Hill, B. T.; Monneret, C. J. Med. Chem. 1998, 41, 4475-4485.
25. Kim, S.; Kee, I. S.; Park, Y. H.; Park, J. H. Synlett 1991, 183-184.
26. (a) Gildersleeve, J.; Smith, A.; Sakurai, K.; Raghavan, S.; Kahne, D. J. Am. Chem. Soc. 1999, 121, 6176-6182.
27. (b) Gildersleeve, J.; Pascal, R. A.; Kahne, D. J. Am. Chem. Soc. 1998, 120, 5961-5969
28. (c) Yan, L.; Kahne, D. J. Am. Chem. Soc. 1996, 118, 9239-9248.
29. (d) Liang, R.; Yan, L.; Loebach, J.; Ge, M.; Uozumi, Y.; Sekanina, K.; Horan, N.; Gildersleeve, J.; Thompson, C.; Smith, A.; Biswas, K.; Still, W. C.; Kahne, D. Science 1996, 274, 1520-1522
30. (e) Berkowitz, D. B.; Danishefsky, S. J.; Schulte, G. J. Am. Chem. Soc. 1992, 114, 4518-4529.
31. (f) Kahne, D.; Walker, S.; Cheng Y.; Van Engen, D. J. Am. Chem. Soc. 1989, 11, 6881-6882.
32. For both complementary mechanistic studies and the application of Kahne glycosylation chemistry to β-mannopyranosides, see: (a) Crich, D.; Li, H. J. Org. Chem. 2000, 65, 801-805.
33. (b) Crich, D.; Sun, S. Tetrahedron 1998, 54, 8321-8348.
34. (c) Crich, D.; Sun, S. J. Am. Chem. Soc. 1997, 119, 11217-11223.
35. (a) Di Bussolo, V.; Liu, J.; Huffman, L. G., Jr.; Gin, D. Y. Angew. Chem., Int. Ed. 2000, 39, 204-207.
36. (b) Di Bussolo, V.; Kim, Y.-J.; Gin, D. Y. J. Am. Chem. Soc. 1998, 120, 13515-13516.
37. (c) Garcia, B. A.; Poole, J. L.; Gin, D. Y. J. Am. Chem. Soc. 1997, 119, 7597-7598.
38. N1-like transition state, all of the analogous, aglycon-based electrophiles are conceivable activated intermediates here.
39. (a) Zhu, X.-K.; Guan, J.; Tachibana, Y.; Bastow, K. F.; Cho, S. J.; Cheng, H.-H.; Cheng, Y.-C.; Gurwith, M.; Lee, K.-H. J. Med. Chem. 1999, 42, 2441-2446.
40. (b) Daley, L.; Meresse, P.; Bertounesque, E.; Monneret, C. Tetrahedron Lett. 1997, 38, 2673-2676.
41. (c) Zhou, X.-M.; Lee, K. J.-H.; Cheng, J.; Wu, S.-S.; Chen, H.-X.; Guo, X.; Cheng, Y.-C.; Lee, K.-H. J. Med. Chem. 1994, 37, 287-292.
42. Matsumoto, T.; Katsuki, M.; Suzuki, K. Tetrahedron Lett. 1988, 29, 6935-6938.
43. Terada, T.; Fujimoot, F.; Nomura, M.; Yamashita, J.-C.; Wierzba, K.; Yamazaki, R.; Shibata, J.; Sugimoto, Y.; Yamada, Y.; Kobunai, T.; Takeda, S.; Minami, Y.; Yoshida, K.; Yamaguchi, H. J. Med. Chem. 1993, 36, 1689-1699.
44. (a) Mootoo, D. R.; Konradsson, P.; Udodong, U.; Fraser-Reid, B. J. Am. Chem. Soc. 1988, 110, 5583-5584.
45. (b) Friesen, R. W.; Danishefsky, S. J. J. Am. Chem. Soc. 1989, 111, 6656-6660.